Rectal Cancer
Al B. Benson, Tanios Bekaii‐Saab, Emily W. Chan et al. · Journal of the National Comprehensive Cancer Network · 2012
These NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of rectal cancer, beginning with the clinical presentation of the patient to the primary care physician or gastroenterologist through diagnosis, pathologic staging, neoadjuvant treatment, surgical management, adjuvant treatment, surveillance, management of recurrent and metastatic disease, and survivorship. This discussion focuses on localized disease. The NCCN Rectal Cancer Panel believes that a multidisciplinary approach, including representation from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology, is necessary for treating patients with rectal cancer.
Cited by 146 works. doi:10.6004/jnccn.2012.0158 Open-access PDF
Authors
- Al B. Benson
- Tanios Bekaii‐Saab
- Emily W. Chan
- Yi‐Jen Chen
- Michael A. Choti
- Harry S. Cooper
- Paul F. Engstrom
- Peter C. Enzinger
- Marwan Fakih
- Charles S. Fuchs
- Jean L. Grem
- Lucille Leong
- Michael Gary Martin
- Kilian Salerno May
- Mary F. Mulcahy
- ERIC M. ROHREN
- David P. Ryan
References
- SEER Cancer Statistics Review, 1975-2003
- Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
- The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?
- Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
- Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
- Hereditary Colorectal Cancer
- Role of circumferential margin involvement in the local recurrence of rectal cancer
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery